Skip to main content
SpringerLink
Log in

Psychedelika

  • Living reference work entry
  • First Online:
Handbuch Psychoaktive Substanzen

Part of the book series: Springer Reference Psychologie ((SRP))

  • 911 Accesses

Zusammenfassung

Psychedelika (klassische bzw. serotonerge Halluzinogene) sind psychoaktive Substanzen, welche Wahrnehmung, Affekte sowie eine Reihe kognitiver Prozesse intensiv verändern können. Die Mehrheit ihrer Vertreter gilt als physiologisch sicher und nicht addiktiv. Ihre Geschichte reicht bis in prähistorische Zeit zurück. Mit der Entdeckung der Wirkstoffe Meskalin, Lysergsäurediethylamid (LSD), Dimethyltryptamin (DMT) und Psilocybin begann sowohl ihre wissenschaftliche Erforschung als auch die Verbreitung ihres nicht medizinischen Gebrauchs. Psychedelika stellen eine pharmakologisch, psychometrisch und tierexperimentell abgrenzbare Substanzklasse dar, die zunehmend im Interesse der medizinischen Grundlagen- und Therapieforschung steht. Dieses Kapitel strebt hinsichtlich der relevanten Wissensgebiete einen ausgewogenen Kurzüberblick über die Substanzklasse und ihre wichtigsten Vertreter an, wobei dem historisch komplexen Wirkgefüge zwischen Medizin- und Sozialgeschichte der Substanzklasse ein Schwerpunkt gewidmet ist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Literatur

  • Appel, J., & Cunningham, K. (1985). The use of drug discrimination procedures to characterize hallucinogenic drug actions. Psychopharmacology Bulletin, 22(3), 959–967.

    Google Scholar 

  • Araújo, A., Carvalho, F., Bastos, M. D., Guedes de Pinho, P., & Carvalho, M. (2015). The hallucinogenic world of tryptamines: An updated review. Archives of Toxicology, 89(8), 1151–1173. doi:10.1007/s00204-015-1513-x.

    Article  PubMed  Google Scholar 

  • Baker, E. F. (1964). The use of lysergic acid diethylamide (LSD) in psychotherapy. Canadian Medical Association Journal, 91, 1200–1202.

    PubMed  PubMed Central  Google Scholar 

  • Barker, S. A., McIlhenny, E. H., & Strassman, R. (2012). A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955–2010. Drug Testing and Analysis, 4(7–8), 617–635. doi:10.1002/dta.422.

    Article  PubMed  Google Scholar 

  • Bauer, V. H. (1973). Ergotismus-Epidemien in der Überlieferung vom Altertum bis heute. Das Antonius-Feuer in Kunst und Medizin (S. 33–51). Berlin/Heidelberg: Springer.

    Book  Google Scholar 

  • Baumeister, R. F., & Placidi, K. S. (1983). A social history and analysis of the LSD controversy. Journal of Humanistic Psychology, 23(4), 25–58. doi:10.1177/0022167883234003.

    Article  Google Scholar 

  • Beringer, K. (1927). Der Meskalinrausch: seine Geschichte und Erscheinungsweise. Berlin: Springer.

    Book  Google Scholar 

  • Bogenschutz, M. P., & Johnson, M. W. (2015). Classic hallucinogens in the treatment of addictions. Progress in Neuro-Psychopharmacology and Biological Psychiatry. doi:10.1016/j.pnpbp.2015.03.002.

    PubMed  Google Scholar 

  • Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study. Journal of Psychopharmacology, 29(3), 289–299. doi:10.1177/0269881114565144.

    Article  PubMed  Google Scholar 

  • Böszörményi, Z., & Szára, S. (1958). Dimethyltryptamine experiments with psychotics. The British Journal of Psychiatry, 104, 445–453.

    Article  Google Scholar 

  • Brandt, S. D., Kavanagh, P. V., Westphal, F., Stratford, A., Elliott, S. P., Hoang, K., Wallach, J., & Halberstadt, A. L. (2015). Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD). Drug Testing and Analysis, 8, 891–902. doi:10.1002/dta.1884.

    Article  PubMed  Google Scholar 

  • Brandt, S. D., Kavanagh, P. V., Westphal, F., Elliott, S. P., Wallach, J., Colestock, T., Burrow, T. E., Chapman, S. J., Stratford, A., Nichols, D. E., & Halberstadt, A. L. (2017). Return of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2’S,4’S)-lysergic acid 2,4-dimethylazetidide (LSZ). Drug Testing and Analysis, 9, 38–50. doi:10.1002/dta.1985.

    Article  PubMed  Google Scholar 

  • Buckholtz, N. S., Zhou, D., Freedman, D. X., & Potter, W. Z. (1990). Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain. Neuropsychopharmacology, 3(2), 137–148.

    PubMed  Google Scholar 

  • Calabrese, J. D. (2013). A different medicine: Postcolonial healing in the Native American Church. Oxford: Oxford University Press.

    Book  Google Scholar 

  • Carbonaro, T. M., & Gatch, M. B. (2016). Neuropharmacology of N,N-dimethyltryptamine. Brain Research Bulletin, 126, 74–88. doi:10.1016/j.brainresbull.2016.04.016.

    Article  PubMed  Google Scholar 

  • Carhart-Harris, R. L., Kaelen, M., Whalley, M. G., Bolstridge, M., Feilding, A., & Nutt, D. J. (2015). LSD enhances suggestibility in healthy volunteers. Psychopharmacology, 232(4), 785–794. doi:10.1007/s00213-014-3714-z.

    Article  PubMed  Google Scholar 

  • Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., Taylor, D., Pilling, S., Curran, V. H., & Nutt, D. J. (2016a). Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. The Lancet Psychiatry, 3, 619–627. doi:10.1016/S2215-0366(16)30065-7.

    Article  PubMed  Google Scholar 

  • Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L., Kaelen, M., Droog, W., Murphy, K., Tagliazucchi, E., Schenberg, E. E., Nest, T., Orban, C., Leech, R., Williams, L. T., Williams, T. M., Bolstridge, M., Sessa, B., McGonigle, J., Sereno, M. I., Nichols, D., Hellyer, P. J., Hobden, P., Evans, J., Singh, K. D., Wise, R. G., Curran, H. V., Feilding, A., & Nutt, D. J. (2016b). Neural correlates of the LSD experience revealed by multimodal neuroimaging. Proceedings of the National Academy of Sciences, 113(17), 4853–4858. doi:10.1073/pnas.1518377113.

    Article  Google Scholar 

  • Carod-Artal, F. (2014). Hallucinogenic drugs in pre-Columbian Mesoamerican cultures. Neurología (English Edition), 30(1), 42–49.

    Article  Google Scholar 

  • Christian, S. T., Harrison, R., Quayle, E., Pagel, J., & Monti, J. (1977). The in vitro identification of dimethyltryptamine (DMT) in mammalian brain and its characterization as a possible endogenous neuroregulatory agent. Biochemical Medicine, 18(2), 164–183.

    Article  PubMed  Google Scholar 

  • De Mori, B. B. (2011). Tracing hallucinations: Contributing to a critical ethnohistory of Ayahuasca usage in the Peruvian Amazon. Paper presented at the The Internationalization of Ayahuasca.

    Google Scholar 

  • DeRios, M. D. (1994). Drug tourism in the amazon. Anthropology of Consciousness, 5(1), 16–19. doi:10.1525/ac.1994.5.1.16.

    Article  Google Scholar 

  • Dittrich, A. (1998). The standardized psychometric assessment of altered states of consciousness (ASCs) in humans. Pharmacopsychiatry, 31(S2), 80–84. doi:10.1055/s-2007-979351.

    Article  PubMed  Google Scholar 

  • El-Seedi, H. R., Smet, P. A. G. M. D., Beck, O., Possnert, G., & Bruhn, J. G. (2005). Prehistoric peyote use: Alkaloid analysis and radiocarbon dating of archaeological specimens of Lophophora from Texas. Journal of Ethnopharmacology, 101(1–3), 238–242. doi:10.1016/j.jep.2005.04.022.

    Article  PubMed  Google Scholar 

  • Fontanilla, D., Johannessen, M., Hajipour, A. R., Cozzi, N. V., Jackson, M. B., & Ruoho, A. E. (2009). The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator. Science, 323(5916), 934–937.

    Article  PubMed  PubMed Central  Google Scholar 

  • Froese, T., Guzmán, G., & Guzmán-Dávalos, L. (2016). On the origin of the genus psilocybe and its potential ritual use in Ancient Africa and Europe1. Economic Botany, 70, 103–114. doi:10.1007/s12231-016-9342-2.

    Article  Google Scholar 

  • Gallimore, A. R., & Luke, D. (2015). DMT Research from 1956 to the edge of time. In D. King & D. Luke (Hrsg.), Neurotransmissions: Essays on psychedelics from breaking convention. London: Strange Attractor.

    Google Scholar 

  • Gasser, P., Kirchner, K., & Passie, T. (2015). LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects. Journal of Psychopharmacology, 29(1), 57–68. doi:10.1177/0269881114555249.

    Article  PubMed  Google Scholar 

  • Gresch, P. J., Smith, R. L., Barrett, R. J., & Sanders-Bush, E. (2005). Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Neuropsychopharmacology, 30(9), 1693–1702.

    Article  PubMed  Google Scholar 

  • Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187(3), 268–283.

    Article  PubMed  Google Scholar 

  • Griffiths, R. R., Richards, W., Johnson, M., McCann, U., & Jesse, R. (2008). Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of Psychopharmacology, 22(6), 621–632. doi:10.1177/0269881108094300.

    Article  PubMed  PubMed Central  Google Scholar 

  • Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011). Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology, 218(4), 649–665. doi:10.1007/s00213-011-2358-5.

    Article  PubMed  PubMed Central  Google Scholar 

  • Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30(12), 1181–1197. doi:10.1177/0269881116675513.

    Article  PubMed  PubMed Central  Google Scholar 

  • Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011). Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of General Psychiatry, 68(1), 71–78. doi:10.1001/archgenpsychiatry.2010.116.

    Article  PubMed  Google Scholar 

  • Grof, S. (1976). Realms of the human unconscious: Observations from LSD research. Coventry: Condor Books.

    Google Scholar 

  • Grof, S. (1980). LSD Psychotherapy. Santa Cruz: MAPS.

    Google Scholar 

  • Guzmán, G., Allen, J. W., & Gartz, J. (1998). A worldwide geographical distribution of the neurotropic fungi, an analysis and discussion. Annali dei Musei Civici di Rovereto. Sezione: Archeologia, Storia, Scienze Naturali, 14, 189–280.

    Google Scholar 

  • Halberstadt, A. L. (2015). Recent advances in the neuropsychopharmacology of serotonergic hallucinogens. Behavioural Brain Research, 277, 99–120. doi:10.1016/j.bbr.2014.07.016.

    Article  PubMed  Google Scholar 

  • Halberstadt, A. L., & Geyer, M. A. (2011). Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens. Neuropharmacology, 61(3), 364–381. doi:10.1016/j.neuropharm.2011.01.017.

    Article  PubMed  PubMed Central  Google Scholar 

  • Halpern, J., Suzuki, J., Huertas, P., & Passie, T. (2014). Hallucinogen Abuse and Dependence. In I. P. Stolerman & L. H. Price (Hrsg.), Encyclopedia of psychopharmacology (S. 1–5). Berlin/Heidelberg: Springer.

    Google Scholar 

  • Hasler, F., Grimberg, U., Benz, M. A., Huber, T., & Vollenweider, F. X. (2004). Acute psychological and physiological effects of psilocybin in healthy humans: A double-blind, placebo-controlled dose – effect study. Psychopharmacology, 172(2), 145–156.

    Article  PubMed  Google Scholar 

  • Heffter, A. (1896). Ueber cacteenalkaloide. Berichte der Deutschen Chemischen Gesellschaft, 29(1), 216–227.

    Article  Google Scholar 

  • Hendricks, P. S., Thorne, C. B., Clark, C. B., Coombs, D. W., & Johnson, M. W. (2015). Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. Journal of Psychopharmacology, 29(3), 280–288.

    Article  PubMed  Google Scholar 

  • Hermle, L., Fünfgeld, M., Oepen, G., Botsch, H., Borchardt, D., Gouzoulis, E., Fehrenbach, R. A., & Spitzer, M. (1992). Mescaline-induced psychopathological, neuropsychological, and neurometabolic effects in normal subjects: Experimental psychosis as a tool for psychiatric research. Biological Psychiatry, 32(11), 976–991. doi:10.1016/0006-3223(92)90059-9.

    Article  PubMed  Google Scholar 

  • Hermle, L., Gouzoulis-Mayfrank, E., & Spitzer, M. (1998). Blood flow and cerebral laterality in the mescaline model of psychosis. Pharmacopsychiatry, 31(S2), 85–91.

    Article  PubMed  Google Scholar 

  • Hofmann, A. (1993). LSD – mein Sorgenkind: die Entdeckung einer „Wunderdroge“. München: DTV.

    Google Scholar 

  • Hofmann, A., & Stoll, A. (1948). 2,438,259. d-Lysergic Acid Diethyl Amide. Arthur Stoll and Albert Hofmann, Basel, Switzerland, assignors to Sandoz Ltd., Fribourg, Switzerland, a Swiss firm. United States Patent and Trademark Office. Patents. Search for Patents. Searching PDF Image Patents (Since 1790). http://patft.uspto.gov/netahtml/PTO/patimg.htm.

  • Hofmann, A., & Tscherter, H. (1960). Isolierung von Lysergsäure-Alkaloiden aus der mexikanischen Zauberdroge Ololiuqui (Rivea corymbosa (L.) Hall. f.). Experientia, 16(9), 414–414. doi:10.1007/BF02178840.

    Article  PubMed  Google Scholar 

  • Hofmann, A., Heim, R., Brack, A., & Kobel, H. (1958). Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen Rauschpilz Psilocybe mexicana Heim. Experientia, 14(3), 107–109. doi:10.1007/BF02159243.

    Article  PubMed  Google Scholar 

  • Horita, A., & Weber, L. (1961). Dephosphorylation of psilocybin to psilocin by alkaline phosphatase. Experimental Biology and Medicine, 106(1), 32–34.

    Article  Google Scholar 

  • Huxley, A. (1954). Die Pforten der Wahrnehmung: meine Erfahrung mit Meskalin. München: Piper.

    Google Scholar 

  • Johansen, P.-Ø., & Krebs, T. S. (2015). Psychedelics not linked to mental health problems or suicidal behavior: A population study. Journal of Psychopharmacology, 29, 270–279.

    Article  PubMed  Google Scholar 

  • Kesey, K. (1963). One flew over the Cuckoo’s Nest. New York: Viking Press & Signet Books.

    Google Scholar 

  • Krebs, T. S., & Johansen, P.-Ø. (2012). Lysergic acid diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials. Journal of Psychopharmacology, 26(7), 994–1002. doi:10.1177/0269881112439253.

    Article  PubMed  Google Scholar 

  • Labate, B. C., & Jungaberle, H. (2011). The internationalization of Ayahuasca. Berlin/Münster/Wien/Zürich/London: LIT.

    Google Scholar 

  • Leary, T. (1970). The politics of ecstasy. London: Paladin.

    Google Scholar 

  • Lee, M. A., & Shlain, B. (1985). Acid dreams: The CIA, LSD, and the sixties rebellion. New York: Grove Press.

    Google Scholar 

  • Leuner, H. (1963). Die Psycholytische Therapie: Klinische Psychotherapie mit Hilfe von LSD-25 und verwandten Substanzen. Zeitschrift für Psychotherapie und Medizinische Psychologie, 13, 57–64.

    PubMed  Google Scholar 

  • Leuner, H. (1966). Psychotherapie mit Hilfe von Halluzinogenen. Arzneimittel-Forschung, 16, 253–255.

    PubMed  Google Scholar 

  • Leuner, H. (1971). Halluzinogene in der Psychotherapie. Pharmacopsychiatry, 4(6), 333–351.

    Article  Google Scholar 

  • Leuner, H. (1981). Halluzinogene: psychische Grenzzustände in Forschung und Psychotherapie. Bern: Hans Huber.

    Google Scholar 

  • Majić, T., Schmidt, T. T., & Gallinat, J. (2015). Peak experiences and the afterglow phenomenon: When and how do therapeutic effects of hallucinogens depend on psychedelic experiences? Journal of Psychopharmacology, 29(3), 241–253. doi:10.1177/0269881114568040.

    Article  PubMed  Google Scholar 

  • Majić, T., Schmidt, T. T., & Hermle, L. (2016). Flashbacks und anhaltende Wahrnehmungsstörungen nach Einnahme von serotonergen Halluzinogenen. In M. von Heyden, H. Jungaberle & T. Majić (Hrsg.), Handbuch Psychoaktive Substanzen. Berlin/Heidelberg: Springer.

    Google Scholar 

  • McKenna, D. J. (1998). Ayahuasca: An ethnopharmacologic history. In R. Metzner (Hrsg.), Sacred vine of spirits – Ayahuasca. Rochester/Vermont: Park Street Press.

    Google Scholar 

  • McKenna, D. J., Towers, G. H. N., & Abbott, F. (1984). Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca. Journal of Ethnopharmacology, 10(2), 195–223. doi:10.1016/0378-8741(84)90003-5.

    Article  PubMed  Google Scholar 

  • Millman, R. B., & Beeder, A. B. (1994). The new psychedelic culture: LSD, ecstasy, „rave“ parties and the grateful dead. Psychiatric Annals, 24(3), 148–150.

    Article  Google Scholar 

  • Moreno, F. A., Wiegand, C. B., Taitano, E. K., & Delgado, P. L. (2006). Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. Journal of Clinical Psychiatry, 67(11), 1735–1740.

    Article  PubMed  Google Scholar 

  • Naranjo, P. (1979). Hallucinogenic plant use and related indigenous belief systems in the ecuadorian amazon. Journal of Ethnopharmacology, 1(2), 121–145. doi:10.1016/0378-8741(79)90003-5.

    Article  PubMed  Google Scholar 

  • Nichols, D. E. (2016). Psychedelics. Pharmacological Reviews, 68(2), 264–355. doi:10.1124/pr.115.011478.

    Article  PubMed  PubMed Central  Google Scholar 

  • Oak, A., Hanna, J., Nielsen, K., & Mishor, T. (2015). The manual of psychedelic support. Psychedelic Care Publications. http://psychsitter.com.

  • Oberlender, R., & Nichols, D. E. (1988). Drug discrimination studies with MDMA and amphetamine. Psychopharmacology, 95(1), 71–76.

    Article  PubMed  Google Scholar 

  • Osmond, H. (1957). A review of the clinical effects of psychotomimetic agents. Annals of the New York Academy of Sciences, 66(3), 418–434. doi:10.1111/j.1749-6632.1957.tb40738.x.

    Article  PubMed  Google Scholar 

  • Ott, J. (1993). Pharmacotheon: Entheogenic drugs, their plant sources, and history. Kennewick: Natural Products Company.

    Google Scholar 

  • Pahnke, W., & Richards, W. (1966). Implications of LSD and experimental mysticism. Journal of Religion and Health, 5(3), 175–208. doi:10.1007/BF01532646.

    Article  PubMed  Google Scholar 

  • Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008). The pharmacology of lysergic acid diethylamide: A review. CNS Neuroscience & Therapeutics, 14(4), 295–314. doi:10.1111/j.1755-5949.2008.00059.x.

    Article  Google Scholar 

  • Pfeiffer-Gerschel, T., Jakob, L., & Stumpf, D. (2014). Bericht 2014 des nationalen REITOX-Knotenpunkts an die EBDD. Neue Entwicklung und Trends Deutschland. Drogensituation 2013/2014. Deutsche Hauptstelle für Suchtfragen. http://www.dhs.de/fileadmin/user_upload/pdf/EBDD_Jahresberichte/REITOX_Report_2014_Germany_DE.pdf.

  • Ray, T. S. (2010). Psychedelics and the human receptorome. PloS One, 5(2), e9019. doi:10.1371/journal.pone.0009019.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ross, C. A. (2006). The C.I.A. doctors: Human rights violations by American psychiatrists. Richardson: Manitou Communications.

    Google Scholar 

  • Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., Su, Z., Corby, P., & Schmidt, B. L. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology, 30(12), 1165–1180. doi:10.1177/0269881116675512.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ruck, C. A., & Staples, D. (1994). The world of classical myth: Gods and goddesses, heroines and heroes. Durham: Carolina Academic Press.

    Google Scholar 

  • Ruck, C. A., Bigwood, J., Staples, D., Ott, J., & Wasson, R. G. (1979). Entheogens. Journal of Psychoactive Drugs, 11(1–2), 145–146.

    Article  Google Scholar 

  • Salm-Reifferscheidt-Dyck, J. Z. (1845). Beschreibung einiger neuen Cacteen welche im Fürstlich Salm-Dyck'schen Garten cultivirt werden. Allgemeine Gartenzeitung, 13, 385–386.

    Google Scholar 

  • Schmid, J. T. (2010). Subjektive Theorien zu Selbst-Behandlungsversuchen mit der psychoaktiven Substanz Ayahuasca. Heidelberg: Univeristät Heidelberg Dissertation.

    Google Scholar 

  • Schmidt, T. T., & Majić, T. (2016). Empirische Untersuchung veränderter Bewusstseinszustände. In M. von Heyden, H. Jungaberle & T. Majić (Hrsg.), Handbuch Psychoaktive Substanzen. Berlin/Heidelberg: Springer.

    Google Scholar 

  • Schultes, R. E. (1957). The identity of the malpighiaceous narcotics of South America. Botanical Museum Leaflets, 18(1), 1–56. doi:10.2307/41762183.

    Google Scholar 

  • Sessa, B. (2016). The History of Psychedelics in Medicine. In M. von Heyden, H. Jungaberle & T. Majić (Hrsg.), Handbuch Psychoaktive Substanzen. Berlin/Heidelberg: Springer.

    Google Scholar 

  • Sewell, R. A., Halpern, J. H., & Pope, H. G., Jr. (2006). Response of cluster headache to psilocybin and LSD. Neurology, 66(12), 1920–1922. doi:10.1212/01.wnl.0000219761.05466.43.

    Article  PubMed  Google Scholar 

  • Shulgin, A. T. (1978). Psychotomimetic Drugs: Structure-Activity Relationships Stimulants. In L. L. Iversen, S. D. Iversen & S. H. Snyder (Hrsg.), Handbook of psychopharmacology (Stimulants, Bd. 11, S. 243–333). New York: Plenum Press.

    Google Scholar 

  • Shulgin, A. T., Manning, T., & Daley, P. F. (2011). The Shulgin Index. Volume 1. Psychedelic phenethylamines and related compounds. Berkeley: Transform Press.

    Google Scholar 

  • Smith, D. E. (1969). Use of LSD in the Haight-Ashbury – Observations at a neighborhood clinic. California Medicine, 110(6), 472–476.

    PubMed  PubMed Central  Google Scholar 

  • Späth, E. (1919). Über die Anhalonium-Alkaloide. Monatshefte für Chemie und verwandte Teile anderer Wissenschaften, 40(2), 129–154. doi:10.1007/BF01524590.

    Article  Google Scholar 

  • St John, G. (2012). Global tribe: Technology, spirituality and psytrance. Sheffield: Equinox.

    Google Scholar 

  • Stoll, A., & Hofmann, A. (1943). Partialsynthese von Alkaloiden vom Typus des Ergobasins (6. Mitteilung über Mutterkornalkaloide). Helvetica Chimica Acta, 26(3), 944–965. doi:10.1002/hlca.19430260326.

    Article  Google Scholar 

  • Strassman, R. J. (1984). Adverse reactions to psychedelic drugs. A review of the literature. The Journal of Nervous and Mental Disease, 172(10), 577–595.

    Article  PubMed  Google Scholar 

  • Strassmann, R. J. (1995). Hallucinogenic drugs in psychiatric research and treatment perspectives and prospects. The Journal of Nervous and Mental Disease, 183(3), 127–138.

    Article  Google Scholar 

  • Studerus, E., Gamma, A., & Vollenweider, F. X. (2010). Psychometric evaluation of the altered states of consciousness rating scale (OAV). PloS One, 5(8), e12412. doi:10.1371/journal.pone.0012412.

    Article  PubMed  PubMed Central  Google Scholar 

  • Studerus, E., Kometer, M., Hasler, F., & Vollenweider, F. X. (2011). Acute, subacute and long-term subjective effects of psilocybin in healthy humans: A pooled analysis of experimental studies. Journal of Psychopharmacology, 25(11), 1434–1452.

    Article  PubMed  Google Scholar 

  • Sumnall, H. (2016). Epidemiologie des Konsums von neuen psychoaktiven Substanzen. In M. von Heyden, H. Jungaberle & T. Majić (Hrsg.), Handbuch psychoaktive substanzen. Berlin/Heidelberg: Springer.

    Google Scholar 

  • Tanner, J. (1998). „The Times They Are A-Changin“: Zur subkulturellen Dynamik der 68er Bewegungen. Geschichte und Gesellschaft, 17, 207–223.

    Google Scholar 

  • Taylor, R. L., Maurer, J. I., & Tinklenberg, J. R. (1970). Management of „bad trips“ in an evolving drug scene. JAMA, 213(3), 422–425. doi:10.1001/jama.1970.03170290018003.

    Article  PubMed  Google Scholar 

  • Thomasius, R., Gouzoulis-Mayfrank, E., Karus, C., Wiedenmann, H., Hermle, L., Sack, P. M., Zeichner, D., Küstner, U., Schindler, A., Krüger, A., Uhlmann, S., Petersen, K. U., Zapletalova, P., Wartberg, L., Schütz, C. G., Schulte-Markwort, M., Obrocki, J., Heinz, A., & Schmoldt, A. (2004). AWMF-Behandlungsleitlinie: Psychische und Verhaltensstörungen durch Kokain, Amphetamine, Ecstasy und Halluzinogene [AWMF-guideline: Cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders]. Fortschritte der Neurologie-Psychiatrie, 72(12), 679–695. doi:10.1055/s-2004-818531.

    Article  PubMed  Google Scholar 

  • Trachsel, D., Lehmann, D., & Enzensperger, C. (2013). Phenethylamine: von der Struktur zur Funktion. Solothurn: Nachtschatten.

    Google Scholar 

  • Vollenweider, F. X., & Preller, K. H. (2016). Neurobiologische Grundlagen der Wirkung von Psychedelika. In M. von Heyden, H. Jungaberle & T. Majić (Hrsg.), Handbuch psychoaktive substanzen. Berlin/Heidelberg: Springer.

    Google Scholar 

  • Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998). Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. NeuroReport, 9(17), 3897–3902.

    Article  PubMed  Google Scholar 

  • Wallach, J. (2009). Endogenous hallucinogens as ligands of the trace amine receptors: A possible role in sensory perception. Medical Hypotheses, 72(1), 91–94.

    Article  PubMed  Google Scholar 

  • Wasson, R. G. (1959). Division of Mycology: The Hallucinogenic Mushrooms of Mexiko. An adventure in ethnomycological exploration. Transactions of the New York Academy of Sciences, 21(4II), 325–339. doi:10.1111/j.2164-0947.1959.tb00681.x.

    Google Scholar 

  • Wasson, V. P., & Wasson, R. G. (1952). Mushrooms, Russia and history. New York: Pantheon Books.

    Google Scholar 

  • Wasson, R. G., Hofmann, A., & Ruck, C. A. (1978). The road to Eleusis. Unveiling the secret of the mysteries. New York/London: HB Jovanovich.

    Google Scholar 

  • Wasson, R. G., Kramrisch, S., Ott, J., & Ruck, C. A. (1986). Persephone’s quest: Entheogens and the origins of religion. New Haven: Yale University Press.

    Google Scholar 

  • Weinhold, J. (2010). Eigengebrauch psychoaktiver Substanzen in medizinisch-therapeutischen Berufen: eine methodenintegrative Studie über Formen und Kontexte des kontrollierten Konsums illegaler Drogen. Heidelberg: Universität Heidelberg.

    Google Scholar 

  • Wolfe, T. (1969). The electric Kool-aid acid test. New York: Bantam Books.

    Google Scholar 

  • Zaggl, F. S. (1856). Das Mutterkorn. Secale cornutum. Inaugural-Dissertation. München: Druck der M. Pössenbacher’schen Buchdruckerei.

    Google Scholar 

  • Zinberg, N. E. (1984). Drug, set, and setting: The basis for controlled intoxicant use. New Haven: Yale University Press.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centrum für Human- und Gesundheitswissenschaften, Charité Universitätsmedizin, Berlin, Deutschland

    Maximilian von Heyden

  2. FINDER Institut für Präventionsforschung, Palisadenstr. 67, 10243, Berlin, Deutschland

    Maximilian von Heyden

  3. FINDER Institut für Präventionsforschung, Palisadenstr. 67, 10243, Berlin, Deutschland

    Henrik Jungaberle

Authors
  1. Maximilian von Heyden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Henrik Jungaberle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maximilian von Heyden .

Editor information

Editors and Affiliations

  1. FINDER academy and research , Berlin, Germany

    Maximilian von Heyden

  2. FINDER academy and research , Berlin, Germany

    Henrik Jungaberle

  3. St. Hedwig Krankenhaus, Charité Universitätsmedizin Berlin St. Hedwig Krankenhaus, Berlin, Berlin, Germany

    Tomislav Majić

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer-Verlag GmbH Deutschland

About this entry

Cite this entry

von Heyden, M., Jungaberle, H. (2017). Psychedelika. In: von Heyden, M., Jungaberle, H., Majić, T. (eds) Handbuch Psychoaktive Substanzen. Springer Reference Psychologie . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55214-4_43-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55214-4_43-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-55214-4

  • Online ISBN: 978-3-642-55214-4

  • eBook Packages: Springer Referenz Psychologie

Publish with us

Policies and ethics

Search

Navigation